Highlights ImmuCell Corporation

Stocks

ICCC

US4525253062

Pharmaceuticals

Delayed Nasdaq 15:45:01 2026-09-14 EDT			5-day change	1st Jan Change
9.800 ^USD	-0.51%		-0.41%	+59.35%

08-14	ImmuCell Corporation, Q2 2026 Earnings Call, Aug 14, 2026
08-13	ImmuCell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Highlights

08-13	ImmuCell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-14	ImmuCell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-08	ImmuCell, Norbrook enter settlement deed on May 8, 2026 - SEC filing	RE
04-08	ImmuCell Q1 Sales Jump; Shares Rise After Hours	MT
03-04	ImmuCell Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
12-24	Immucell Announces Strategic Focus on First Defense® After Receiving an Fda Incomplete Letter for Re-Tain®	CI
11-13	Animal health firm ImmuCell Q3 sales fall 8%, hurt by previous production interruptions	RE
11-13	ImmuCell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-08-14	ImmuCell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-05-14	ImmuCell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-04-08	ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025	RE
25-04-02	ImmuCell Corporation Announces Initiation of Investigational Product Use of Re-Tain	CI
25-02-25	ImmuCell Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024	CI
25-01-09	ImmuCell Preliminary Q4 Sales Rise, Production Exceeds Capacity, Backlog Reduced	MT
25-01-09	ImmuCell Corporation Provides Preliminary Unaudited Sales Results for the Fourth Quarter and Full Year Ended December 31, 2024	CI
24-11-13	ImmuCell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
24-10-08	Immucell Corporation Provides Preliminary Unaudited Sales Results for the Third Quarter, Nine Months and Twelve Months Ended September 30, 2024	CI
24-08-13	ImmuCell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
24-07-09	ImmuCell Corporation Provides Preliminary Unaudited Sales Results for the Second Quarter, Six Months and Twelve Months Ended June 30, 2024	CI
24-06-05	ImmuCell Corporation Provides Update on Regulatory Status of Product Development Initiative for Re-Tain®	CI
24-05-14	ImmuCell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24-04-09	Immucell Corporation Reports Unaudited Sales Results for the Three Months and Twelve Months Ended March 31, 2024	CI
24-02-27	ImmuCell Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-02-27	ImmuCell Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI
23-11-13	ImmuCell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI